Single-use Technology for Biopharmaceuticals Market Growth, Demand, Recent Trends, Size by Forecast to 2026

Editorial & Advertiser Disclosure Global Banking And Finance Review is an independent publisher which offers News, information, Analysis, Opinion, Press Releases, Reviews, Research reports covering various economies, industries, products, services and companies. The content available on is sourced by a mixture of different methods which is not limited to content produced and supplied by various staff writers, journalists, freelancers, individuals, organizations, companies, PR agencies etc. The information available on this website is purely for educational and informational purposes only. We cannot guarantee the accuracy or applicability of any of the information provided at with respect to your individual or personal circumstances. Please seek professional advice from a qualified professional before making any financial decisions. also links to various third party websites and we cannot guarantee the accuracy or applicability of the information provided by third party websites.
Links from various articles on our site to third party websites are a mixture of non-sponsored links and sponsored links. Only a very small fraction of the links which point to external websites are affiliate links. Some of the links which you may click on our website may link to various products and services from our partners who may compensate us if you buy a service or product or fill a form or install an app. This will not incur additional cost to you. For avoidance of any doubts and to make it easier, you may consider any links to external websites as sponsored links. Please note that some of the services or products which we talk about carry a high level of risk and may not be suitable for everyone. These may be complex services or products and we request the readers to consider this purely from an educational standpoint. The information provided on this website is general in nature. Global Banking & Finance Review expressly disclaims any liability without any limitation which may arise directly or indirectly from the use of such information.

The rapid utilization of single-use disposables to prevent contamination in the healthcare environment is driving the global single-use technology for biopharmaceuticals market, says Fortune Business Insights in a report, titled “Single-use Technology for Biopharmaceuticals Market Size, Share and Global Trend By Product Type (Equipment, Consumables), By End-user (Biopharmaceutical Manufacturer, Academic Clinical Research Institutes, Others) and Geography Forecast till 2026.” Rising need for upstream and downstream purification during manufacturing is a factor promoting the global single-use technology for biopharmaceuticals market.

Browse Complete Report Details @

Some of the Main Key Players Covered in the Report

  • Electric Company
  • Aber Instruments Ltd
  • Kühner AG
  • Robert Bosch Packaging Technology GmbH
  • Hamilton Medical
  • Merck KgaA
  • Terumo Corporation
  • GEMÜ Gruppe
  • Infors AG
  • Levitronix

New Product Launches Will Boost Growth in North America

Geographically, the global single-use technology for biopharmaceuticals market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. The single-use technology for biopharmaceuticals market in North America and Europe is predicted to grow at a faster pace during the forecast period owing to the frequent new pharmaceutical product launches.

Get Sample PDF Brochure @

The increasing trend of strategic planning, as well as research collaborations in pharmaceutical industries, is also predicted to aid growth in the above regions. Additionally, the stringent regulatory guidelines for bioprocessing is anticipated to increase the adoption of single-use technologies in Europe and North America. Asia Pacific is expected to grow at a considerable rate owing to the presence of various upcoming pharmaceutical production plants and rapid acceptance of the use of single-use disposables.

Key Segmentation:

By Product Type

  • Equipment
  • Consumables

By End-user

  • Biopharmaceutical Manufacturer
  • Academic and Clinical Research Institutes

By Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Launch of New Single-Use Technologies by Milliporesigma Will Encourage Growth

Milliporesigman, a global life science company announced three new products designed to make single-use bioprocessing safer, easier, and more efficient. The launch of Pellicon capsule, Millipak final fill filter and Mobius Power MIX 2500-liter and 3000-liter are likely to aid the global single-use technology for biopharmaceuticals growth owing to the bioprocessing innovation in the new superior single-use technologies.

The award won by the Milliporesigman for best technological innovation at INTERPHEX 2018 will have also have a progressive impact on the market. Furthermore, the launch of Single-Use Chromatography System is also expected to contribute to the global single-use technology for biopharmaceuticals revenue. For instance, Pall Corporation. launched Allegro Single-Use Chromatography System that can be used in a flow range of 10 to 900 L/h.

More Trending Topics from Fortune Business Insights:

Thrombin Market Technological strategies, Size, Share, Industry Trends, Forecast Analysis by 2026

Retinal Disease Therapeutics Market 2019: Trends, Emerging Market Regions, Growth Factors, CAGR Status, Revenue Expectation 2026

Wound Care Devices Market Stand Out as the Biggest Contributor to Global Growth and Will Hit 5.1% CAGR By 2026